1. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011; 17:1791–1798.
2. Xu Y, Gu B, Huang M, Liu H, Xu T, Xia W, Wang T. Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000–2012 in Asia. J Thorac Dis. 2015; 7:376–385.
3. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007; 51:763–765.
4. Lee HJ, Choi JK, Cho SY, Kim SH, Park SH, Choi SM, Lee DG, Choi JH, Yoo JH. Carbapenem-resistant Enterobacteriaceae: prevalence and risk factors in a single community-based hospital in Korea. Infect Chemother. 2016; 48:166–173.
5. Bar-Yoseph H, Cohen N, Korytny A, Andrawus ER, Even Dar R, Geffen Y, Hussein K, Paul M. Risk factors for mortality among carbapenem-resistant Enterobacteriaceae carriers with focus on immunosuppression. J Infect. 2019; 78:101–105.
6. Ling ML, Tee YM, Tan SG, Amin IM, How KB, Tan KY, Lee LC. Risk factors for acquisition of carbapenem resistant
Enterobacteriaceae in an acute tertiary care hospital in Singapore. Antimicrob Resist Infect Control. 2015; 4:26.
7. Shi K, Wood K, Shi FD, Wang X, Liu Q. Stroke-induced immunosuppression and poststroke infection. Stroke Vasc Neurol. 2018; 3:34–41.
8. Kang SH, Choi YJ, Lee KH, Kim YH, Chang WH, Shin MA, Kim DY, Lee J, Sohn MK, Lee SG, Kim SY, Shin YI, Lee YS, Joo MC, Oh GJ, Lee YH, Han EY, Han JH, Ahn J. The Korean stroke cohort for functioning and rehabilitation (KOSCO). Public Health Weekly Report. 2018; 11:1152–1162.
9. Lee KB, Lim SH, Kim KH, Kim KJ, Kim YR, Chang WN, Yeom JW, Kim YD, Hwang BY. Six-month functional recovery of stroke patients: a multi-time-point study. Int J Rehabil Res. 2015; 38:173–180.
11. Briggs DE, Felberg RA, Malkoff MD, Bratina P, Grotta JC. Should mild or moderate stroke patients be admitted to an intensive care unit? Stroke. 2001; 32:871–876.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40:373–383.
13. Torres-Gonzalez P, Cervera-Hernandez ME, Niembro-Ortega MD, Leal-Vega F, Cruz-Hervert LP, García-García L, Galindo-Fraga A, Martinez-Gamboa A, Bobadilla-Del Valle M, Sifuentes-Osornio J, Ponce-de-Leon A. Factors associated to prevalence and incidence of carbapenem-resistant Enterobacteriaceae fecal carriage: a cohort study in a Mexican Tertiary Care Hospital. PLoS One. 2015; 10:e0139883.
14. Ampaire LM, Katawera V, Nyehangane D, Boum Y, Bazira J. Epidemiology of carbapenem resistance among multi-drug resistant Enterobacteriaceae in Uganda. Br Microbiol Res J. 2015; 8:418–423.
15. Kim J, Lee JY, Kim SI, Song W, Kim JS, Jung S, Yu JK, Park KG, Park YJ. Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea. Ann Lab Med. 2014; 34:20–25.
16. Kim DK, Kim HS, Pinto N, Jeon J, D'Souza R, Kim MS, Choi JY, Yong D, Jeong SH, Lee K. Xpert CARBA-R assay for the detection of carbapenemase-producing organisms in intensive care unit patients of a Korean Tertiary Care Hospital. Ann Lab Med. 2016; 36:162–165.
17. Giannella M, Trecarichi EM, De Rosa FG, Del Bono V, Bassetti M, Lewis RE, Losito AR, Corcione S, Saffioti C, Bartoletti M, Maiuro G, Cardellino CS, Tedeschi S, Cauda R, Viscoli C, Viale P, Tumbarello M. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study. Clin Microbiol Infect. 2014; 20:1357–1362.
18. Correa L, Martino MD, Siqueira I, Pasternak J, Gales AC, Silva CV, Camargo TZ, Scherer PF, Marra AR. A hospital-based matched case-control study to identify clinical outcome and risk factors associated with carbapenem-resistant
Klebsiella pneumoniae infection. BMC Infect Dis. 2013; 13:80.
19. Jeon MH, Choi SH, Kwak YG, Chung JW, Lee SO, Jeong JY, Woo JH, Kim YS. Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis. 2008; 62:402–406.
20. Jiao Y, Qin Y, Liu J, Li Q, Dong Y, Shang Y, Huang Y, Liu R. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study. Pathog Glob Health. 2015; 109:68–74.
21. Ahn JY, Song JE, Kim MH, Choi H, Kim JK, Ann HW, Kim JH, Jeon Y, Jeong SJ, Kim SB, Ku NS, Han SH, Song YG, Yong D, Lee K, Kim JM, Choi JY, et al. Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study. Am J Infect Control. 2014; 42:621–625.
22. Teo J, Cai Y, Tang S, Lee W, Tan TY, Tan TT, Kwa AL. Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study. PLoS One. 2012; 7:e34254.
23. Asai N, Sakanashi D, Suematsu H, Kato H, Hagihara M, Nishiyama N, Koizumi Y, Yamagishi Y, Mikamo H. The epidemiology and risk factor of carbapenem-resistant Enterobacteriaceae colonization and infections: case control study in a single institute in Japan. J Infect Chemother. 2018; 24:505–509.
24. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern cooperative oncology group. Am J Clin Oncol. 1982; 5:649–655.
25. Song JY, Jeong IS. Development of a risk prediction model of carbapenem-resistant Enterobacteriaceae colonization among patients in intensive care units. Am J Infect Control. 2018; 46:1240–1244.
26. Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008; 7:341–353.
27. Choi SH. Diagnosis and treatment of nosocomial infections in neurological intensive care units. J Neurocrit Care. 2014; 7:63–70.
28. Karam G, Chastre J, Wilcox MH, Vincent JL. Antibiotic strategies in the era of multidrug resistance. Crit Care. 2016; 20:136.
29. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008; 52:1028–1033.
30. Faigle R, Sharrief A, Marsh EB, Llinas RH, Urrutia VC. Predictors of critical care needs after IV thrombolysis for acute ischemic stroke. PLoS One. 2014; 9:e88652.
31. Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, Lin M, Stemer A, Weinstein RA. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010; 31:341–347.
32. Go E, Ju S, Yoo J, Jeon S. Distribution of carbapenem-resistant Enterobacteriaceae (CRE) in Korea, 2017. Public Health Weekly Report. 2018; 11:1518–1522.
33. Lavagnoli LS, Bassetti BR, Kaiser TDL, Kutz KM, Cerutti C Junior. Factors associated with acquisition of carbapenem-resistant
Enterobacteriaceae. Rev Lat Am Enfermagem. 2017; 25:e2935.
34. Chopra T, Rivard C, Awali RA, Krishna A, Bonomo RA, Perez F, Kaye KS. Epidemiology of carbapenem-resistant
Enterobacteriaceae at a long-term acute care hospital. Open Forum Infect Dis. 2018; 5:ofy224.
35. Yang J, Ye L, Guo L, Zhao Q, Chen R, Luo Y, Chen Y, Tian S, Zhao J, Shen D, Han L. A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. Clin Microbiol Infect. 2013; 19:E509–E515.
36. Sheppard AE, Stoesser N, Wilson DJ, Sebra R, Kasarskis A, Anson LW, Giess A, Pankhurst LJ, Vaughan A, Grim CJ, Cox HL, Yeh AJ, Sifri CD, Walker AS, Peto TE, Crook DW, Mathers AJ. Modernising Medical Microbiology (MMM) Informatics Group. Nested Russian doll-like genetic mobility drives rapid dissemination of the carbapenem resistance gene blaKPC. Antimicrob Agents Chemother. 2016; 60:3767–3778.
37. Schwartz-Neiderman A, Braun T, Fallach N, Schwartz D, Carmeli Y, Schechner V. Risk Factors for carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) acquisition among contacts of newly diagnosed CP-CRE patients. Infect Control Hosp Epidemiol. 2016; 37:1219–1225.